[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
DOI=10.1038/355609a0; PubMed=1538748 [NCBI, ExPASy, EBI, Israel, Japan]
Zamore P.D.,
Patton J.G.,
Green M.R.;
"Cloning and domain structure of the mammalian splicing factor U2AF.";
Nature 355:609-614(1992).
|
[2]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J.,
Istrail S.,
Sutton G.G.,
Florea L.,
Halpern A.L.,
Mobarry C.M.,
Lippert R.,
Walenz B.,
Shatkay H.,
Dew I.,
Miller J.R.,
Flanigan M.J.,
Edwards N.J.,
Bolanos R.,
Fasulo D.,
Halldorsson B.V.,
Hannenhalli S.,
Turner R.,
Yooseph S.,
Lu F.,
Nusskern D.R.,
Shue B.C.,
Zheng X.H.,
Zhong F.,
Delcher A.L.,
Huson D.H.,
Kravitz S.A.,
Mouchard L.,
Reinert K.,
Remington K.A.,
Clark A.G.,
Waterman M.S.,
Eichler E.E.,
Adams M.D.,
Hunkapiller M.W.,
Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
|
[3]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
TISSUE=Lymph, and Skin;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan] The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[4]
|
PROTEIN SEQUENCE OF 2-9; 196-203; 277-286 AND 463-471, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, AND MASS SPECTROMETRY.
TISSUE=Colon carcinoma;
Bienvenut W.V.,
Heiserich L.,
Boulahbel H.,
Gottlieb E.;
Submitted (NOV-2006) to UniProtKB.
|
[5]
|
PROTEIN SEQUENCE OF 261-286, MASS SPECTROMETRY, AND INTERACTION WITH THE SPLICEOSOME.
DOI=10.1101/gr.473902; PubMed=12176931 [NCBI, ExPASy, EBI, Israel, Japan]
Rappsilber J.,
Ryder U.,
Lamond A.I.,
Mann M.;
"Large-scale proteomic analysis of the human spliceosome.";
Genome Res. 12:1231-1245(2002).
|
[6]
|
INTERACTION WITH SFRS2IP.
PubMed=9447963 [NCBI, ExPASy, EBI, Israel, Japan]
Zhang W.-J.,
Wu J.Y.;
"Sip1, a novel RS domain-containing protein essential for pre-mRNA splicing.";
Mol. Cell. Biol. 18:676-684(1998).
|
[7]
|
INTERACTION WITH SF1.
DOI=10.1093/emboj/18.16.4549; PubMed=10449420 [NCBI, ExPASy, EBI, Israel, Japan]
Wang X.,
Bruderer S.,
Rafi Z.,
Xue J.,
Milburn P.J.,
Kraemer A.,
Robinson P.J.;
"Phosphorylation of splicing factor SF1 on Ser20 by cGMP-dependent protein kinase regulates spliceosome assembly.";
EMBO J. 18:4549-4559(1999).
|
[8]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND MASS SPECTROMETRY.
TISSUE=Hepatocyte;
DOI=10.1002/pmic.200401217; PubMed=16097034 [NCBI, ExPASy, EBI, Israel, Japan]
Gevaert K.,
Staes A.,
Van Damme J.,
De Groot S.,
Hugelier K.,
Demol H.,
Martens L.,
Goethals M.,
Vandekerckhove J.;
"Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC.";
Proteomics 5:3589-3599(2005).
|
[9]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-53; SER-55 AND SER-79, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1016/j.cell.2006.09.026; PubMed=17081983 [NCBI, ExPASy, EBI, Israel, Japan]
Olsen J.V.,
Blagoev B.,
Gnad F.,
Macek B.,
Kumar C.,
Mortensen P.,
Mann M.;
"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.";
Cell 127:635-648(2006).
|
[10]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1021/pr070152u; PubMed=17924679 [NCBI, ExPASy, EBI, Israel, Japan]
Yu L.-R.,
Zhu Z.,
Chan K.C.,
Issaq H.J.,
Dimitrov D.S.,
Veenstra T.D.;
"Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
J. Proteome Res. 6:4150-4162(2007).
|
[11]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0611217104; PubMed=17287340 [NCBI, ExPASy, EBI, Israel, Japan]
Molina H.,
Horn D.M.,
Tang N.,
Mathivanan S.,
Pandey A.;
"Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.";
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
|
[12]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, AND MASS SPECTROMETRY.
DOI=10.2116/analsci.24.161; PubMed=18187866 [NCBI, ExPASy, EBI, Israel, Japan]
Imami K.,
Sugiyama N.,
Kyono Y.,
Tomita M.,
Ishihama Y.;
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Anal. Sci. 24:161-166(2008).
|
[13]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, AND MASS SPECTROMETRY.
DOI=10.1021/pr0705441; PubMed=18220336 [NCBI, ExPASy, EBI, Israel, Japan]
Cantin G.T.,
Yi W.,
Lu B.,
Park S.K.,
Xu T.,
Lee J.-D.,
Yates J.R. III;
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.";
J. Proteome Res. 7:1346-1351(2008).
|
[14]
|
STRUCTURE BY NMR OF 148-237.
DOI=10.1093/emboj/18.16.4523; PubMed=10449418 [NCBI, ExPASy, EBI, Israel, Japan]
Ito T.,
Muto Y.,
Green M.R.,
Yokoyama S.;
"Solution structures of the first and second RNA-binding domains of human U2 small nuclear ribonucleoprotein particle auxiliary factor (U2AF(65)).";
EMBO J. 18:4523-4534(1999).
|
[15]
|
STRUCTURE BY NMR OF 372-475 IN COMPLEX WITH SF1, AND MUTAGENESIS OF 387-GLU-GLU-388; 391-ASP--GLU-393; 396-GLU-GLU-397 AND PHE-454.
DOI=10.1016/S1097-2765(03)00115-1; PubMed=12718882 [NCBI, ExPASy, EBI, Israel, Japan]
Selenko P.,
Gregorovic G.,
Sprangers R.,
Stier G.,
Rhani Z.,
Kraemer A.,
Sattler M.;
"Structural basis for the molecular recognition between human splicing factors U2AF65 and SF1/mBBP.";
Mol. Cell 11:965-976(2003).
|
[16]
|
X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 90-112 IN COMPLEX WITH U2AF1, AND MUTAGENESIS OF TRP-92; PRO-96 AND PRO-104.
DOI=10.1016/S0092-8674(01)00480-9; PubMed=11551507 [NCBI, ExPASy, EBI, Israel, Japan]
Kielkopf C.L.,
Rodionova N.A.,
Green M.R.,
Burley S.K.;
"A novel peptide recognition mode revealed by the X-ray structure of a core U2AF35/U2AF65 heterodimer.";
Cell 106:595-605(2001).
|
|